Remedy Acquires Axtive Assets
The Axtive products will provide Remedy, its partners and customers the technology needed to interact with each individual Web-site visitor, whether they are first-time visitors or pre-existing customers.
Twenty percent of companies assume their data quality tools pay off, while another 10% doesn't monitor ROI at all.
Ensighten's purchase of the analytics company is about giving ultimate ownership of data to marketers, says CEO Josh Manion.
Experts break down the up- and downsides of popular vanity metrics, such as Facebook likes and Twitter followers.